The enzyme Pantothenate synthetase (PS) represents a potential drug target in Mycobacterium tuberculosis. Its X-ray crystallographic structure has demonstrated the significance and importance of conserved active site residues including His44, His47, Asn69, Gln72, Lys160 and Gln164 in substrate binding and formation of pantoyl adenylate intermediate. In the current study, molecular mechanism of decreased affinity of the enzyme for ATP caused by alanine mutations was investigated using molecular dynamics (MD) simulations and free energy calculations. A total of seven systems including wildtype + ATP, H44A + ATP, H47A + ATP, N69A + ATP, Q72A + ATP, K160A + ATP and Q164A + ATP were subjected to 50 ns MD simulations. Docking score, MM-GBSA and interaction profile analysis showed weak interactions between ATP (substrate) and PS (enzyme) in H47A and H160A mutants as compared to wild-type, leading to reduced protein catalytic activity. However, principal component analysis (PCA) and free energy landscape (FEL) analysis revealed that ATP was strongly bound to the catalytic core of the wild-type, limiting its movement to form a stable complex as compared to mutants. The study will give insight about ATP binding to the PS at the atomic level and will facilitate in designing of nonreactive analogue of pantoyl adenylate which will act as a specific inhibitor for PS.The causative agent of tuberculosis (TB) is Mycobacterium tuberculosis (Mtb), a major infectious bacterium which spreads through droplets in the air. TB is second only to HIV/AIDS as the major killer across the globe 1 . Multi-drug resistant Mtb is becoming a regular health problem especially in immuno-compromised individuals with HIV 2 . This form of TB is more difficult to treat and as a result has higher mortality rate. Because of this, the discovery of drugs targeting novel pathways such as the synthesis of pantothenate has become increasingly important. The World Health statistics report in 2014 stated that 9.6 million people were diagnosed with TB of which 1.5 million people died 3 . PanC gene encodes Pantothenate Synthetase (PS; EC 6.3.2.1) responsible for producing pantothenate (vitamin B5), is a promising drug target owing to a few important reasons 4 . Firstly, it is present in all bacteria but absent in mammals, a key factor for the selective activity of drug molecule 5 . Secondly, Pantothenate is notable for its role in the synthesis of coenzyme A (CoA) and acyl carrier protein (ACP), essential components of fatty acid synthesis which maintain persistent growth and pathogenicity of the M. tuberculosis 6 . Lastly, Jacob et al., conducted research on a TB vaccine which compromised panC auxotrophs' growth and virulence rigorously supporting the theory of functional necessity of Pantothenate Synthetase pathway and enhancing its attractiveness as a potential antimicrobial target 7 . PS proceeds by Bi Uni Uni Bi Ping Pong kinetic reactions; it catalyzes the ATP dependent condensation of pantoate with beta-alanine via a pantoyl adenylate intermediate as follo...